ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals

Name: ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals
Creator: Therapeutic Goods Administration
Keywords: australia,guidelines,scientific,testing

Information

Original link

Type

International scientific guidelines adopted in Australia

Regulated products

Medical Devices

Topics

Medicines Safety, Prescription Medicines, Therapeutic Goods Regulation

Published

July 17, 2024

Last updated

July 17, 2024

Description

We have adopted this International Scientific Guideline - ICH S1B(R1); EMA/774371/2022

Organization

Therapeutic Goods Administration (TGA) 🇦🇺

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

2 Main files

ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals

Updated on July 17, 2024

pdf

URL: https://www.tga.gov.au/sites/default/files/2024-07/international-scientific-guideline-ich-s1b-r1-ema-774371-2022_0.pdf
Permalink: https://data.openrid.co/en/datasets/r/4667528a-5206-4d4f-866a-df8bf2d8f989
MIME Type: application/pdf

Created on: July 17, 2024
Modified on: July 17, 2024

ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals

Updated on July 17, 2024

html

URL: https://www.tga.gov.au/resources/resource/international-scientific-guidelines/ich-guideline-s1br1-testing-carcinogenicity-pharmaceuticals
Permalink: https://data.openrid.co/en/datasets/r/bb7f6f3e-a881-4a40-9c13-458030ebf485
MIME Type: text/html

Created on: July 17, 2024
Modified on: July 17, 2024

ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals

Information

Type

Regulated products

Topics

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed